PMID: 9654194Jul 8, 1998Paper

Impaired granulocytic function in patients with acute leukaemia: only partial normalisation after successful remission-inducing treatment

Journal of Cancer Research and Clinical Oncology
W K HofmannK Höffken

Abstract

In vivo chemotaxis and phagocytic activity of polymorphonuclear neutrophils (PMN) were evaluated in 20 patients with acute myeloid leukaemia (AML), and in 10 patients with acute lymphoblastic leukaemia (ALL). For comparison, 20 healthy individuals were investigated. A skin-chamber technique and a phagocytosis test were used to quantify the neutrophil functions. The local leucocyte mobilisation in the skin-chamber was significantly lower in untreated patients with AML and ALL than in healthy individuals (P < 0.05). Patients with acute leukaemia in remission showed an increase in chemotactic parameters though they remained below normal levels. The phagocytosis index (PI) of peripheral blood PMN was lower than 30% (normal individuals: 60%) in untreated AML and ALL; this difference was significant (P < 0.05). The PI of peripheral blood PMN in patients with acute leukaemia in remission returned to the normal level. Investigation of granulocytic function in patients with acute leukaemia in remission may reveal evidence for reduced protection by these cells against infections and lead to adequate therapy.

Citations

Sep 4, 2009·International Journal of Hematology·Fumiko TanakaShumpei Yokota
Jan 30, 2015·Clinical Lymphoma, Myeloma & Leukemia·Syed M KazmiJorge Cortes
May 9, 2014·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Takeshi AsanoMiho Maeda
Jan 31, 2007·Luminescence : the Journal of Biological and Chemical Luminescence·A PustovidkoY Evtodienko
Mar 28, 2007·Journal of Clinical Laboratory Analysis·Marília P P KanegaeLuiz Marcos da Fonseca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.